PSMA uptake (SUV(bw)max) and DWI MRI (ADCmax and ADCmin) were found to be distinct biomarkers able to differentiate between clinically significant PCa and normal prostatic tissue in naïve prostate cancer patients with a Gleason Score ≥7 [34,35]. Here, FOLH1 is linked to posterior cortical atrophy.